» Authors » Stefan Munker

Stefan Munker

Explore the profile of Stefan Munker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 480
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Link F, Li Y, Zhao J, Munker S, Fan W, Nwosu Z, et al.
Gut . 2024 Oct; 74(3):424-439. PMID: 39448254
Objective: Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth factor-β1 (TGF-β1) in its latent form. ECM1 knockout (KO) causes latent (L) TGF-β1...
2.
Wang S, Link F, Munker S, Wang W, Feng R, Liebe R, et al.
Hepatol Commun . 2024 Jul; 8(8). PMID: 39023343
Background: When massive necrosis occurs in acute liver failure (ALF), rapid expansion of HSCs called liver progenitor cells (LPCs) in a process called ductular reaction is required for survival. The...
3.
Ben Khaled N, Mortl B, Beier D, Reiter F, Pawlowska-Phelan D, Teufel A, et al.
Eur J Cancer . 2023 Dec; 198:113499. PMID: 38160177
No abstract available.
4.
Munker S, Roessler D, Ocal O, Ben-Khaled N, Bernhart K, Ye L, et al.
Oncol Res Treat . 2023 Oct; 46(11):466-475. PMID: 37827135
Introduction: Immunotherapy has been established as the standard treatment option for patients with advanced hepatocellular carcinoma (aHCC). Despite the increased efficacy, disease progression occurs in a relevant proportion of patients...
5.
Feng R, Tong C, Lin T, Liu H, Shao C, Li Y, et al.
Am J Pathol . 2023 Oct; 194(1):52-70. PMID: 37820926
Loss of hepatocyte nuclear factor 4α (HNF4α) expression is frequently observed in end-stage liver disease and associated with loss of vital liver functions, thus increasing mortality. Loss of HNF4α expression...
6.
Ben Khaled N, Mortl B, Beier D, Reiter F, Pawlowska-Phelan D, Teufel A, et al.
Eur J Cancer . 2023 Sep; 192:113248. PMID: 37672814
Background And Aims: The treatment of hepatocellular carcinoma (HCC) is undergoing a historic transformation with the approval of several new systemic therapies in the last few years. This study aimed...
7.
Staudacher J, Backes M, Bettinger D, Bluthner E, Dietz-Fricke C, Dugic A, et al.
Z Gastroenterol . 2023 Aug; 61(8):997-999. PMID: 37567237
No abstract available.
8.
Ye L, Ziesch A, Schneider J, Ofner A, Niess H, Denk G, et al.
Aging Dis . 2023 Jun; 15(1):338-356. PMID: 37307826
Primary sclerosing cholangitis (PSC) represents a chronic liver disease characterized by poor prognosis and lacking causal treatment options. Yes-associated protein (YAP) functions as a critical mediator of fibrogenesis; however, its...
9.
Ben Khaled N, Hammer K, Ye L, Alnatsha A, Widholz S, Piseddu I, et al.
Cancers (Basel) . 2022 Nov; 14(21). PMID: 36358659
Chemotherapy, the standard treatment for pancreatic ductal adenocarcinoma (PDAC), has only a modest effect on the outcome of patients with late-stage disease. Investigations of the genetic features of PDAC have...
10.
Vogg J, Maier-Stocker C, Munker S, Mehrl A, Schlosser S, Tews H, et al.
Front Med (Lausanne) . 2022 Oct; 9:1008450. PMID: 36300192
Background And Aims: Liver diseases are frequent causes of morbidity and mortality worldwide. Liver diseases can lead to cirrhosis, with the risk of acute-on-chronic liver failure (ACLF). For the detection...